Kevin Goodwin
Executive Director
Signostics
Australia
Biography
Kevin Goodwin became CEO of Signostics in 2015 following multiple accomplishments in his 3-decade career as an innovator in the ultrasound industry. Most notably, he founded and served as CEO of the multinational point-of-care innovator SonoSite Inc., and capped his 17-year tenure there with its $1 billion sale to Fujifilm in 2012. Earlier, he held various managerial positions at ATL Ultrasound, Inc., including Vice President and General Manager of the company’s Handheld Systems Business Group.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
